...
首页> 外文期刊>Kidney International Reports >Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and?Results in Reduced?Hypoglycemia
【24h】

Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and?Results in Reduced?Hypoglycemia

机译:低剂量胰岛素疗法治疗高钾血症有效且可降低低血糖症

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction Complications associated with insulin treatment for hyperkalemia are serious and common. We hypothesize that, in chronic kidney disease (CKD) and end-stage renal disease (ESRD), giving 5 units instead of 10 units of i.v. regular insulin may reduce the risk of causing hypoglycemia when treating hyperkalemia. Methods A retrospective quality improvement study on hyperkalemia management (K + ?≥ 6 mEq/l) from June 2013 through December 2013 was conducted at an urban emergency department center. Electronic medical records were reviewed, and data were extracted on presentation, management of hyperkalemia, incidence and timing of hypoglycemia, and whether treatment was ordered as a protocol through computerized physician order entry (CPOE). We evaluated whether an educational effort to encourage the use of a protocol through CPOE that suggests the use of 5 units might be beneficial for CKD/ESRD patients. A second audit of hyperkalemia management from July 2015 through January 2016 was conducted to assess the effects of intervention on hypoglycemia incidence. Results Treatments ordered using a protocol for hyperkalemia increased following the educational intervention (58 of 78 patients [74%] vs. 62 of 99 patients [62%]), and the number of CKD/ESRD patients prescribed 5 units of insulin as per protocol increased (30 of 32 patients [93%] vs. 32 of 43 [75%], P ?= .03). Associated with this, the incidence of hypoglycemia associated with insulin treatment was lower (7 of 63 patients [11%] vs. 22 of 76 patients [28%], P ?= .03), and there were no cases of severe hypoglycemia compared to the 3 cases before the intervention. Conclusion Education on the use of a protocol for hyperkalemia resulted in a reduction in the number of patients with severe hypoglycemia associated with insulin treatment.
机译:简介与胰岛素治疗有关的高钾血症并发症非常严重和常见。我们假设,在慢性肾脏病(CKD)和终末期肾脏病(ESRD)中,i.v。给予5个单位而不是10个单位。在治疗高钾血症时,定期服用胰岛素可能会降低引起低血糖的风险。方法在2013年6月至2013年12月期间,对城市急诊中心进行高钾血症管理(K +?≥6 mEq / l)的回顾性质量改进研究。审查电子病历,并提取有关表现,高钾血症,低血糖发生率和时机的数据,以及是否通过计算机医生处方录入(CPOE)按协议订购治疗。我们评估了鼓励通过CPOE使用协议的教育工作是否表明使用5个单位可能对CKD / ESRD患者有益。 2015年7月至2016年1月对高钾血症管理进行了第二次审核,以评估干预措施对低血糖发生率的影响。结果教育干预后,按照高钾血症方案订购的治疗有所增加(78名患者中的58名[74%]比99名患者中的62名[62%]),并且根据方案,CKD / ESRD患者处方了5单位胰岛素增加(32名患者中的30名[93%],而43名患者中的32名[75%],P = 0.03)。与此相关的是,与胰岛素治疗相关的低血糖发生率较低(63名患者中的7名[11%]比76名患者中的22名[28%],P = 0.03),并且没有严重的低血糖病例到干预前的3例。结论使用高钾血症方案的教育减少了与胰岛素治疗相关的严重低血糖症患者的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号